Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. NKE
3. PANW
4. CL
5. SNDK
6. TAP
7. DELL
8. ROIV
9. ANET
10. BE

Go back to Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48

Amgen (AMGN) Price Target Raised to $195 at Jefferies

April 22, 2015 11:41 AM EDT

In a note earlier, Jefferies analyst Eun K. Yang reiterated a Buy rating and boosted his price target on Amgen (NASDAQ: AMGN) to $195.00 (from $182.00) following Q1 results.

Yang commented, "Reported ~18% higher EPS (vs. cons) on ~3% higher product sales & lower OpEx; upped FY15 EPS guidance... More

Amgen (AMGN) Price Target Lifted to $187 at Leerink Partners

April 22, 2015 7:49 AM EDT

Leerink Partners analyst Howard Liang reiterated an Outperform rating and boosted estimates and his price target on Amgen (NASDAQ: AMGN) to $187.00 (from $177.00) following strong results.

Liang commented, "AMGN reported a strong first quarter last night, with a broad range of products contributing to a ~$117M sales beat vs. consensus and approximately twice this number in lower-than-expected operating expenses, leading to... More

Amgen (AMGN) Tops Q1 EPS by 38c; Boosts FY15 Outlook

April 21, 2015 4:03 PM EDT

Amgen (NASDAQ: AMGN) reported Q1 EPS of $2.48, $0.38 better than the analyst estimate of $2.10. Revenue for the quarter came in at $5.03 billion versus the consensus estimate of $4.91 billion.

Amgen sees FY2015 EPS of $9.35 - $9.65, versus the consensus of $9.32. Amgen sees FY2015 revenue of $20.9 - $21.3... More